Skip to main content

January 2017

 

 

academics

 

Clinical research courses

Career Opportunity for Pharmacist in Apollo Hospitals - Freshers can Apply | 42 posts

Apollo pharmacy is a leading retail chain of pharmacy and is a unit of - Apollo Hospitals Enterprise Ltd. - Asia's largest healthcare group.  Our growing Retail Pharmacy network touches lives across the length and breadth of India and we serve 200000+ customers a day. With over 30 years of retailing experience, customer-focused service and brand value our network spans out to 2000+ retail pharmacies through which we have been serving our customers for their healthcare needs 24x7.*

Post: Pharmacist/Sr.Pharmacist- 42 posts

Recruitment for Assistant Professor at National Institute of Pharmaceutical Education & Research | Remuneration upto Rs 65000 pm

National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad is a prestigious educational institution of National importance, established in the year 2007 under the aegis of Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt, of India. NIPER, Hyderabad conducts courses in MS (Pharm.), M.Tech (Pharm.) in Pharmaceutical Sciences and MBA (Pharm.) in Pharma Management for Two years. Students are selected through a National Entrance Test (JEE). Research opportunities also exist for those who would like to pursue their Doctoral Degree, The Institute is mentored by CSIR-Indian Institute of Chemical Technology, Hyderabad, a leader in Chemical Technology which is welt known all over the world.

NIPER is now inviting applications for faculty positions on contractual basis initially for a period of one year which is likely to continue based on the performance of the selected candidate.

Job for Officer / Sr. Officer / Executive - R&D (analytical Development) at J. B. Chemicals & Pharmaceuticals Ltd | 06 posts

J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL), known to many as Unique Pharmaceutical Laboratories is one of India's leading global pharmaceutical companies. The company manufactures and markets a wide range of pharmaceutical formulations.

Post:  Officer / Sr. Officer / Executive - R&D (analytical Development) - 06 posts

Vacancy for Product Manager/Executive at Shine Pharmaceuticals Ltd | 06 posts

Shine Pharmaceuticals Ltd is a fast growing Pharmaceutical formulation company having WHO-cGMP and ISO certified manufacturing facilities. We have significant presence throughout India and International markets.
We are manufacturing and marketing oral and injectable formulations in therapeutic segments like Neuro-Psychiatry, Cardiology and Anti-Diabetics

Working opportunity for M.Pharm, M.Sc as Regulatory Affairs Analyst in Novo Nordisk

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post: Regulatory Affairs Analyst

Career for B.Pharm, M.Pharm as Analyst at Novartis

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Post : Analyst- PMR

Job for Director, Science - Chemical Medicines at USP

The U.S.Pharmacopeial Convention (USP) is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed and consumed worldwide. USP’s drug standards are enforceable in the United States by the Food and Drug Administration, and these standards are used in more than 140 countries.

Post : Director, Science - Chemical Medicines

Sunovion Pharmaceuticals Inc. (Sunovion)  announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for Latuda® (lurasidone HCI) for the treatment of schizophrenia in adolescents aged 13 to 17 years. LATUDA is also approved in the U.S. for the treatment of adults with schizophrenia and for the treatment of adults with major depressive episodes associated with bipolar I disorder (bipolar depression) as monotherapy and as adjunctive therapy with lithium or valproate.

Relmada Therapeutics, Inc. announced that the Investigational New Drug (IND) application for d-Methadone (REL-1017 dextromethadone), the company's novel, N-methyl-D-aspartate (NMDA) receptor antagonist, has been cleared by the U.S. Food and Drug Administration (FDA). The company is now authorized to advance the development program for d-Methadone to a Phase 2a proof of concept clinical study in patients with treatment resistant depression (TRD).